Globe Life (GL) filed its fiscal year 2025 10-K annual report with the SEC on Feb 25, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Insurance holding company selling life and supplemental health products to lower-middle-income Americans via direct-to-consumer and exclusive agent channels
- • Established Globe Life Re Ltd. in Bermuda in 2025 — new affiliated reinsurer registered as Class C insurer under BMA supervision for capital efficiency
Management Discussion & Analysis
- • Total premium $4.9B, up 5% YoY; life premium $3.4B (+3%), health premium $1.5B (+9%)
- • Net income $1.16B vs $1.07B; net operating income ROE (ex-AOCI) 16.0% vs prior-year mid-teens target
Risk Factors
- • Legal proceedings costs $13.5M in 2025 and $17M in 2024, indicating ongoing material litigation exposure with no specific resolution timeline
- • Excess investment income fell 16% to $138M in 2025, driven by lower yields on commercial mortgage loans and limited partnerships and constrained asset growth
Financial SummaryXBRL
Revenue
$6.0B
Net Income
$1.2B
Net Margin
19.4%
ROE
19.4%
Total Assets
$30.8B
EPS (Diluted)
$14.07
Operating Cash Flow
$1.4B
Source: XBRL data from Globe Life FY2025 10-K filing on SEC EDGAR. All figures in USD.
Other Globe Life Annual Reports
Get deeper insights on Globe Life
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.